A medicine cannot be sold until a regulator approves it. Whether a product is launched in India or exported to another country, the marketing authorisation holder must submit evidence that the product is safe, effective and manufactured to consistent quality. For most partners working with a contract manufacturer, the largest part of that evidence comes from the manufacturing site: how the product is made, how it is tested and how stable it is.
Kilitch Healthcare supports partners with the manufacturing and quality documentation needed for regulatory submissions. Our experience with sterile injectables, ophthalmic products and other specialised dosage forms helps partners prepare complete, well-organised dossiers and avoid delays in registration.
Many product launches are delayed not by manufacturing problems but by documentation gaps. Common issues include:
Each gap can add months to an approval timeline. Planning documentation alongside development and technology transfer is the most effective way to avoid this.
Many regulators, including those in India and numerous export markets, accept or require dossiers in the Common Technical Document (CTD) format. CTD organises information into five modules:
Module | Content | Typical manufacturing contribution |
Module 1 | Regional administrative information | Site licences, GMP certificates, labelling drafts |
Module 2 | Summaries and overviews | Quality overall summary based on Module 3 data |
Module 3 | Quality | Composition, manufacturing process, controls, specifications, validation, stability |
Module 4 | Non-clinical study reports | Usually literature-based for generics |
Module 5 | Clinical study reports | Bioequivalence or clinical data where required |
For most generic sterile and ophthalmic products, Module 3 is where the manufacturing partner’s input is most important.
Module 3 describes the drug substance and drug product in detail. For the drug product, it typically includes:
Kilitch prepares and supplies the manufacturing and quality information for these sections, in coordination with the partner’s regulatory team.
Regulators look especially closely at sterile products. Dossiers for injectables and eye drops usually need:
Our experience in sterile injectable manufacturing, aseptic pharmaceutical manufacturing and ophthalmic drug manufacturing helps us provide this evidence clearly.
International stability guidelines classify countries into climatic zones. Regulators in hot and humid regions often expect long-term stability data at conditions representing those climates, along with accelerated data. Products must be tested in their final container to support the labelled shelf life.
Because stability studies take time, they should be planned early. Kilitch considers target markets during formulation development and technology transfer so stability programmes match registration plans.
Document | Typical use |
GMP certificate | Proof of site compliance for registration and tenders |
Site master file | Overview of facility, equipment and quality systems |
Certificate of pharmaceutical product (CoPP) | Required by many importing countries |
Free sale certificate | Shows the product is sold in the country of origin, where applicable |
Certificates of analysis | Batch-level quality confirmation |
Samples for registration testing | Required by some regulators |
Kilitch works with partners to arrange these documents according to each market’s rules. Our certifications are listed on our accreditations and certificates page.
After submission, regulators often send questions. Fast, accurate responses keep the review moving. When queries relate to manufacturing, testing or stability, Kilitch’s technical and quality teams work with the partner to prepare responses, provide additional data and clarify processes.
Registration is not the end of documentation. Changes to suppliers, batch size, equipment, process or specifications may need notification or approval in each market. Kilitch’s change control system helps identify when a change may affect registrations so partners can plan variations before implementation.
Regulators frequently raise similar questions on sterile product dossiers. Being prepared for them speeds up approval:
Kilitch prepares supporting data on these topics so partners can respond confidently.
While CTD provides a common structure, each country adds its own requirements. Some require local agents, specific administrative forms or samples for testing. Others ask for prices, labelling in local languages or certificates legalised by embassies. Certain regulators conduct site inspections before approval. Understanding these differences early helps partners plan timelines and budgets realistically. Kilitch shares its experience of common requirements with partners and adapts manufacturing documentation to suit each submission.
Approved dossiers must be kept up to date with renewals, variations and periodic reports, so documentation support continues throughout a product’s life.
Successful submissions depend on close cooperation between the manufacturer and the partner’s regulatory specialists. At project start, Kilitch and the partner agree on target markets, dossier format, timelines and responsibilities. Draft documents are shared for review, comments are resolved, and final versions are issued in a consistent format. Regular meetings during the submission and review period ensure that any regulator questions are answered quickly. This collaborative approach reduces rework and helps products reach approval sooner.
Does Kilitch submit dossiers to regulators?
Submissions are usually made by the marketing authorisation holder. Kilitch provides the manufacturing and quality documentation needed for those submissions.
What is Module 3 of a CTD dossier?
It is the quality module, describing composition, manufacturing, controls, specifications, validation and stability.
Why is stability data so important?
It supports the product’s shelf life and storage conditions, and regulators require it for approval.
What extra data do sterile products need?
Typically sterilisation and aseptic process validation, container closure integrity and sterility, endotoxin and particulate testing.
Can Kilitch help answer regulator queries?
Yes. Our technical and quality teams support responses to manufacturing-related queries.
Tell us about your product and target markets so we can plan manufacturing and documentation together. Contact Kilitch Healthcare or explore our services.